Document is current
Any future updates will be listed below
-
Authors
Fabbri, Lucilla https://orcid.org/0000-0003-2928-3983
Chakraborty, Alina
Robert, Caroline https://orcid.org/0000-0002-9493-0238
Vagner, Stéphan https://orcid.org/0000-0003-1452-7164
- License Information
-
More Information
Article History
Accepted: 14 June 2021
First Online: 2 August 2021
Competing interests
: C.R. is an occasional consultant for Bristol Myers Squibb, MSD, Novartis, Sanofi, AstraZeneca, Pfizer, Roche and Pierre Fabre. C.R. and S.V. are scientific founders of Aglaia Therapeutics. L.F. and A.C. declare no competing interests.
